HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing… HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIR...
Partnership brings the proprietary technology behind Click’s FDA-authorized digital migraine intervention to the Ultrahuman platform… SAN FRANCISCO, Jan. 14, 2026 (GLOBE NEWSWIRE) — Ultrah...
ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera’s Infusion Specialty Therap… BARCELONA & DEERFIELD, Ill....
Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology for the treatment of early-stag… SAN CARLOS, Calif.–(BUSINESS ...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Ami… NEW YORK & NEW ORLEANS...
The “Central Nervous System Therapeutics Market – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market fo… DUBLIN̵...
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted… BORDEAUX, France–(BUSINESS WI...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Mer… NEW YORK CITY & NEW ORLEA...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cid… NEW YORK CITY & NEW ORLEA...
Qualigen Therapeutics Inc. shares exploded in Thursday’s after-hours trading after the company partnered with digital asset firm BitGo to support its multi-asset cryptocurrency treasury strategy...
